Morphic Holding, Inc. (MORF)
NASDAQ: MORF · IEX Real-Time Price · USD
28.66
-1.66 (-5.47%)
Apr 12, 2024, 4:00 PM EDT - Market closed

Morphic Holding Revenue

In the year 2023, Morphic Holding had annual revenue of $521.00K, a decrease of -99.26%.

Revenue (ttm)
$521.00K
Revenue Growth
-99.26%
P/S Ratio
2,752.53
Revenue / Employee
$4,306
Employees
121
Market Cap
1.43B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023521.00K-70.29M-99.26%
Dec 31, 202270.81M51.01M257.72%
Dec 31, 202119.79M-25.15M-55.96%
Dec 31, 202044.95M27.97M164.74%
Dec 31, 201916.98M13.62M405.57%
Dec 31, 20183.36M--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tilray Brands 743.25M
NovoCure 509.34M
ANI Pharmaceuticals 486.82M
Zai Lab 266.72M
LeMaitre Vascular 193.48M
Arcus Biosciences 117.00M
Gyre Therapeutics 113.45M
Avadel Pharmaceuticals 27.96M
Revenue Rankings